Autopsy report · NCT00524485

Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis

“Withdrawn due to low accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 4 months after it had already started.
• Ran for about 4 years before it stopped.
• 12 participants enrolled.
• Results were posted on the registry 8 years after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Roswell Park Cancer Institute

Sponsor type

University, hospital or other

Conditions

Precancerous/Nonmalignant Condition

Interventions

aminolevulinic acid; laser therapy

Participants

12

Sites

1

Countries

United States

Trials that died the same way

• Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
  “Withdrawn due to poor accrual” (97% match in meaning)
• Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
  “Funding withdrawn due to inability to accrue” (76% match in meaning)
• A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029)
  “Withdrawn for administrative reasons” (76% match in meaning)
• The Effects of Sapropterin Dihydrochloride Supplementation on in Vivo Redox Status in Patients With Classical PKU
  “Withdrawn due to no funding” (75% match in meaning)
• Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1
  “Withdrawn due to lack of resources” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.